The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as threats ...

In the competitive world of biotechnology, having a strong online presence is crucial for success. The right SEO agency can ...

CollaMedix, a Cleveland-based medical device company, is poised for growth in 2025 following its recent move to a much larger ...

Analyst Price Forecast Suggests 141.11% Upside As of December 23, 2024, the average one-year price target for Vir Biotechnology is $30.09/share. The forecasts range from a low of $10.10 to a high ...

Sana Biotechnology Background Information (This description is provided by the company.) Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients.

The biotech industry is primed for increased M ... Please note that the full background for this series can be found at the top of the first article belonging to this series.

Massachusetts is a hub for biotech: According to the latest MassBio industry snapshot, biopharma accounted for more than 15% of job growth in the entire state in 2023. This month, we’re hearing from ...

1) The biotech industry is due for accelerating ... Please note that the full background for this series can be found at the top of the first article belonging to this series.

No Oxular employees are joining Regeneron, though several will be “helping short-term with tech transfer and transition work in consulting roles,” a Regeneron spokesperson told Fierce Biotech ...

Carmell acquires Elevai Skincare, adding $2.5M in annual revenue and advanced exosome technology to its portfolio. Deal includes $1.1M in equity, $57K in cash, and earnouts tied to sales and ...

The biotechnology sector once again starts a new year on shaky footing. Acquisitions of publicly traded biotech companies have slowed. An anticipated upswing in initial public offerings hasn’t ...